Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations
Small Methods · 2025
DOI: 10.1002/smtd.202401360 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, 2025. Verfasst von Qin Fan und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Organic Electronics & Information Displays (KLOEID), Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials …. Hauptthemen laut MEDLINE: Nucleic Acids. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 165 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Project of State Key Laboratory of Organic Electronics and Information Displays.
Abstract (Originalsprache)
Tetrahedral framework nucleic acids (tFNAs) are renowned for their controllable self‐assembly, exceptional programmability, and excellent biocompatibility, which have led to their widespread application in the biomedical field. Beyond these features, tFNAs demonstrate unique chemical and biological properties including high cellular uptake efficiency, structural bio‐stability, and tissue permeability, which are derived from their distinctive 3D structure. To date, an extensive range of tFNA‐based nanostructures are intelligently designed and developed for various biomedical applications such as drug delivery, gene therapy, biosensing, and tissue engineering, among other emerging fields. In addition to their role in drug delivery systems, tFNAs also possess intrinsic properties that render them highly effective as therapeutic agents in the treatment of complex diseases, including arthritis, neurodegenerative disorders, and cardiovascular diseases. This dual functionality significantly enhances the utility of tFNAs in biomedical research, presenting valuable opportunities for the development of next‐generation medical technologies across diverse therapeutic and diagnostic platforms. Consequently, this review comprehensively introduces the latest advancements of tFNAs in the biomedical field, with a focus on their benefits and applications as drug delivery nanoplatforms, and their inherent capabilities as therapeutic agents. Furthermore, the current limitations, challenges, and future perspectives of tFNAs are explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Organic Electronics & Information Displays (KLOEID), Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM) and School of Materials Science and Engineering, Nanjing Univers…
- Portland Institute, Nanjing University of Posts and Telecommunications, Nanjing, 210000, China.
ORCID-Profile: Jie Chao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Project of State Key Laboratory of Organic Electronics and Information Displays
- Natural Science Research Start-up Foundation of Recruiting Talents of Nanjing University of Posts and Telecommunications
Zitieren
APA
Fan, Q., Sun, B., & Chao, J. (2025). Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations. Small Methods. https://doi.org/10.1002/smtd.202401360
Vancouver
Fan Q, Sun B, Chao J. Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations. Small Methods. 2025. doi:10.1002/smtd.202401360
BibTeX
@article{Fan2025,
author = {Fan, Qin and Sun, Bicheng and Chao, Jie},
title = {Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202401360}
}
EUVIMED